Bioadhesive Microspheres for Bioavailability Enhancement of Raloxifene Hydrochloride: Formulation and Pharmacokinetic Evaluation

Raloxifene hydrochloride (R-HCl), a BCS class II drug, remains a mainstay in the prevention and pharmacologic therapy of osteoporosis. Its absolute bioavailability, however, is 2% due to poor solubility and extensive first pass metabolism. The present study describes two simultaneous approaches to i...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Jha, Ram K., Tiwari, Sanjay, Mishra, Brahmeshwar
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer US 2011
Témata:
Research Article Theme: Advanced Technologies for Oral Controlled Release Guest Editors: Michael Repka, Joseph Reo, Linda Felton, and Stephen Howard
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3134648/
https://ncbi.nlm.nih.gov/pubmed/21562721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12249-011-9619-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky